Q4 2019 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the BioCryst Fourth Quarter 2019 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. John Bluth at BioCryst. Please go ahead, sir.
Thanks very much, Josh. Good morning, and welcome to BioCryst's Fourth Quarter 2019 Corporate Update and Financial Results Conference Call. Today's press releases and slides to accompany our call are available on our website. Participating with me today are CEO, Jon Stonehouse; Chief Medical Officer, Dr. Bill Sheridan; and Chief Commercial Officer, Charlie Gayer. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |